Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 41 min 1 sec ago

Paradigm Spine, LLC Announces The Publication Of Long-term Results Of Level 1 Data For coflex(R) Interlaminar Stabilization(R)

Tue, 05/12/2015 - 15:40
NEW YORK, May 12, 2015 -- (Healthcare Sales & Marketing Network) -- Paradigm Spine, LLC, a leader in providing solutions for the treatment of advanced degenerative lumbar spinal stenosis announces publication on May 11, 2015 by Hyun Bae, M.D., et al of &q...
Devices, Orthopaedic, Neurosurgery
Paradigm Spine, coflex, Interlaminar Stabilization

Aspyrian Therapeutics Inc. Announces FDA Acceptance of an Investigational New Drug Application for RM-1929, a First-in-Class, Precision-Targeted Therapy for Cancer

Tue, 05/12/2015 - 14:26
SAN DIEGO, May 12, 2015 -- (Healthcare Sales & Marketing Network) -- Aspyrian Therapeutics Inc., a drug development company creating precision-targeted therapies to treat cancer based on its proprietary Photoimmunotherapy platform, today announced the U.S...
Biopharmaceuticals, Oncology, FDA
Aspyrian Therapeutics, Photoimmunotherapy

Merck KGaA, Darmstadt, Germany, Receives FDA Fast Track Designation for Evofosfamide for the Treatment of Patients Living With Advanced Pancreatic Cancer

Tue, 05/12/2015 - 14:19
Evofosfamide is an investigational compound currently in Phase III trials Advanced pancreatic cancer is second indication to receive FDA fast track designation for evofosfamide ROCKLAND, Massachusetts, May 12, 2015 -- (Healthcare Sales & Marketing Ne...
Biopharmaceuticals, Oncology, FDA
EMD Serono, Merck KGaA, evofosfamide, pancreatic cancer

Autonomic Technologies Raises USD 38M in a Transatlantic Series D Financing

Tue, 05/12/2015 - 14:03
REDWOOD CITY, CA--(Healthcare Sales & Marketing Network) - Autonomic Technologies™, Inc. (ATI™), developer and manufacturer of Pulsante™, a microstimulator to treat severe headaches, today announced the closing of a series D round of financing for $38M. Th...
Devices, Neurology, Venture Capital, Personnel
Autonomic Technologies, Pulsante, microstimulator

FDA Grants Priority Review Status for Novocure’s PMA Supplement Application of Optune in Newly Diagnosed Glioblastoma

Mon, 05/11/2015 - 15:42
PMA Supplement application for Tumor Treating Fields in combination with temozolomide chemotherapy for newly diagnosed glioblastoma accepted for filing and review ST. HELIER, Jersey--(Healthcare Sales & Marketing Network)--Novocure, a commercial stage o...
Devices, Oncology, FDA
Novocure, Tumor Treating Fields, Optune, glioblastoma

Cartiva, Inc. Closes $8.5 Million Financing

Mon, 05/11/2015 - 15:37
ALPHARETTA, Ga.--(Healthcare Sales & Marketing Network)--Cartiva, Inc., (Company) a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced that it has secured $8.5 million in an oversubscribed Series D ...
Devices, Venture Capital, Personnel
Cartiva, cartilage implant, cartilage

PaxVax Appoints Nima Farzan Chief Executive Officer

Mon, 05/11/2015 - 15:34
REDWOOD CITY, Calif.--(Healthcare Sales & Marketing Network)--PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, today announced that the Board of Directors has appointed Nima Farzan Chief Executive Officer and President. In this r...
Biopharmaceuticals, Personnel
PaxVax, Vivotif, vaccine

Kane Biotech Announces Change in Executive Leadership

Mon, 05/11/2015 - 14:30
WINNIPEG, MANITOBA--(Healthcare Sales & Marketing Network) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms today announced Gord Froehlich...
Biopharmaceuticals, Personnel
Kane Biotech, microbial biofilms

GW Pharmaceuticals Initiates Phase 3 Pivotal Study of Epidiolex(R) (CBD) in Lennox-Gastaut Syndrome

Mon, 05/11/2015 - 14:03
LONDON, May 11, 2015 -- (Healthcare Sales & Marketing Network) -- GW Pharmaceuticals plc (GWPH) (GWP.L) ("GW," "the Company" or "the Group"), a biopharmaceutical company focused on discovering, developing and commercializing n...
Biopharmaceuticals, Neurology
GW Pharmaceuticals, cannabinoid, Epidiolex, Lennox-Gastaut syndrome

Roche Receives FDA Approval for cobas(R) KRAS Mutation Test

Mon, 05/11/2015 - 13:58
Molecular PCR test identifies KRAS mutations to aid in determining therapy for metastatic colorectal cancer> PLEASANTON, Calif., May 11, 2015 -- (Healthcare Sales & Marketing Network) -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U....
Diagnostics, Oncology, FDA
Roche Group, cobas KRAS, KRAS , metastatic colorectal cancer

Nephros Appoints Malcolm Persen to Board of Directors

Fri, 05/08/2015 - 15:57
RIVER EDGE, N.J.--(Healthcare Sales & Marketing Network)--Nephros, Inc. (NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use...
Devices, Personnel
Nephros, hemodiafiltration, hemodialysis

Armetheon, Inc. Announces Appointment of Andrew C. Lam as Vice President of Product Development

Fri, 05/08/2015 - 15:53
MENLO PARK, Calif., May 8, 2015 -- (Healthcare Sales & Marketing Network) -- Armetheon, Inc., a specialty pharmaceutical company developing novel small molecule drugs for cardiovascular diseases, today announced the appointment of Andrew C. Lam as Vice Pr...
Biopharmaceuticals, Cardiology, Personnel
Armetheon, Tecarfarin, Vitamin K, Vitamin K Antagonist

Provectus Biopharmaceuticals Updates Market on Business Developments

Fri, 05/08/2015 - 15:50
Form 10-Q Filed on Thursday, May 7 Enrollment Open for Phase 3 PV-10 Melanoma Study Patent Protections Expanded in Europe and Japan KNOXVILLE, Tenn.--(Healthcare Sales & Marketing Network)--Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, htt...
Biopharmaceuticals, Dermatology, Oncology
Provectus Biopharmaceuticals, psoriasis

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong